Marker Therapeutics logo
Marker Therapeutics MRKR
$ 1.71 0.59%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Marker Therapeutics EV/EBITDA Ratio 2011-2025 | MRKR

Annual EV/EBITDA Ratio Marker Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.488 -2.47 -3.52 -0.296 -2.5 -2.55 -3.15 -0.799 -2.14 -2.13 -3.12

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.488 -3.52 -2.02